Dr. Kira Minkis, MD, PhD

Dr. Minkis practices at Weill Medical College of Cornell University in New York, New York.

Dr. Minkis' NPI, 1770802258, was assigned on May 24, 2010. Dr. Minkis graduated from New York University School of Medicine in 2009.

Dr. Minkis' primary practice is Weill Medical College of Cornell University, at 1305 York Ave, New York, NY 10021 in New York County. The practice phone is (646) 962-5483.

Dr. Minkis' primary practice is Weill Medical College of Cornell University in New York, New York. Dr. Minkis is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Minkis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Minkis practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Minkis' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Minkis is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Minkis' licenses on file in 2 states: New York and Illinois.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, rash, skin cyst and skin discoloration among the conditions Dr. Minkis treats.

CMS data shows 3,942 Medicare services from Dr. Minkis across 38 procedure codes in 2024, for 805 Medicare patients. Medicare paid $1,025,486 for them. Every service was in an office.

CMS counts 805 Medicare patients who saw Dr. Minkis in 2024. The largest group is 75 to 84, with 347 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Minkis' median patient age at 66, with 46% women.

In 2024, Dr. Minkis wrote 531 Medicare Part D claims for 316 patients. 99% of them were for generic drugs. CMS names the drug for 437 of them, across 8 drugs with 11 or more claims each, at $4,403 in total drug cost. In 2023, CMS named 368 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Minkis for performance year 2024, reported through an alternative payment model (APM). Dr. Minkis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Minkis as offering telehealth. CMS counts 297 procedures of melanoma (skin cancer) excision by Dr. Minkis, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 63 papers to Dr. Minkis, published from 2012 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Skin Neoplasms, Mohs Surgery and Dermatologic Surgical Procedures. Dr. Minkis has published most often in J Am Acad Dermatol. Dr. Minkis' most frequent co-authors are Diana Bolotin, MD, Kishwer S. Nehal, MD and Todd Vincent Cartee, MD.

Dr. Minkis graduated from New York University School of Medicine in 2009.

Dr. Minkis is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.